XML 51 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Collaboration Agreements And Business Development Activities- Royalty Revenues under the Collaboration Agreement with Genentech (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Royalty revenues on ex-U.S. sales $ 411,738 $ 328,423 $ 1,187,145 $ 983,830
Collaborative Arrangement with Genentech | Cotellic        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Profits on U.S. commercialization 1,504 1,743 5,325 5,697
Royalty revenues on ex-U.S. sales $ 1,494 $ 1,576 $ 4,011 $ 3,309